Page last updated: 2024-11-02

phenobarbital and Angiogranuloma

phenobarbital has been researched along with Angiogranuloma in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research Excerpts

ExcerptRelevanceReference
" This study reports five cases of pediatric patients (6 to 12-years-old) diagnosed with Fanconi anemia (FA) after HSCT who presented similar oral mucosal lesions associated with the use of cyclosporine, phenobarbital and amlodipine."4.02A case series of medication-related fibrovascular hyperplasia following hematopoietic stem cell transplantation for Fanconi anemia. ( Ballardin, BS; Bonfim, CMS; Carvalho Torres-Pereira, C; Coracin, FL; Mobile, RZ; Ribeiro, LL; Schussel, JL, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ballardin, BS1
Mobile, RZ1
Coracin, FL1
Ribeiro, LL1
Bonfim, CMS1
Schussel, JL1
Carvalho Torres-Pereira, C1

Other Studies

1 other study available for phenobarbital and Angiogranuloma

ArticleYear
A case series of medication-related fibrovascular hyperplasia following hematopoietic stem cell transplantation for Fanconi anemia.
    Pediatric transplantation, 2021, Volume: 25, Issue:6

    Topics: Amlodipine; Calcium Channel Blockers; Child; Cyclosporine; Fanconi Anemia; Female; Granuloma, Pyogen

2021